Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	84.06	76.68	109.31	78.22	64	9.69
Cash & Cash Equivalents	84.06	76.68	109.31	78.22	64	9.69
Cash Growth	-11.45%	-29.85%	39.74%	22.22%	560.26%	-31.28%
Other Current Assets	1.32	1.59	1.64	1.53	0.93	0.4
Total Current Assets	85.37	78.26	110.94	79.75	64.93	10.09
Property, Plant & Equipment	2.66	2.87	2.95	0.64	1.03	1.14
Long-Term Investments	0.32	0.31	0.3	0	0	0
Other Long-Term Assets	0	0	0	0	0.44	0.44
Total Long-Term Assets	2.98	3.18	3.25	0.64	1.47	1.58
Total Assets	88.35	81.45	114.19	80.39	66.4	11.67
Accounts Payable	7.51	7.95	10.13	5.54	4.34	4.6
Deferred Revenue	35	35	35	1	0	0
Current Debt	0.55	0.54	0.5	0.31	0.43	0.75
Other Current Liabilities	-35	-35	-35	0	0	0
Total Current Liabilities	8.06	8.49	10.63	6.84	4.77	5.34
Long-Term Debt	1.43	1.57	2.08	0	0.31	0.68
Other Long-Term Liabilities	35	35	35	0	0	0
Total Long-Term Liabilities	36.43	36.57	37.08	0	0.31	0.68
Total Liabilities	44.5	45.07	47.71	6.84	5.08	6.03
Total Debt	1.98	2.11	2.58	0.31	0.74	1.43
Debt Growth	-19.43%	-18.13%	732.58%	-57.99%	-48.32%	443.81%
Retained Earnings	-346.25	-337.58	-288.77	-255.75	-230.97	-208.76
Shareholders' Equity	43.86	36.38	66.48	73.55	61.32	5.64
Net Cash / Debt	82.08	74.56	106.73	77.91	63.26	8.27
Net Cash / Debt Growth	-11.23%	-30.13%	36.98%	23.16%	665.41%	-40.29%
Net Cash Per Share	2.94	2.80	4.42	3.79	5.21	1.66
Working Capital	77.31	69.77	100.31	72.91	60.16	4.74
Book Value Per Share	1.57	1.37	2.75	3.58	5.05	1.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).